[Lipids and lipoproteins in atherosclerotic arteriopathy of the legs. Unusual study of very low density lipoproteins]. 1985

D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc

Lipids, apolipoproteins A1 and B and lipoproteins were studied in 49 patients with peripheral arterial disease and in 26 control patients. The observed hypertriglyceridemia was related to the elevation of the VLDL lipid mass; no alteration in their structure could be shown. The origin of this VLDL excess was discussed especially the role of tobacco and genetic.

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001053 Apolipoproteins Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES. Apolipoprotein

Related Publications

D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc
April 1979, Experimental and molecular pathology,
D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc
April 1979, Experimental and molecular pathology,
D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc
January 1983, Arteriosclerosis (Dallas, Tex.),
D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc
January 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire,
D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc
November 1986, La Revue du praticien,
D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc
August 1985, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire,
D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc
March 1988, Journal of lipid research,
D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc
July 1991, Therapeutic drug monitoring,
D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc
January 1996, Medicina,
D Duchassaing, and P Dezellus, and B Guenée, and D Tenenhaus, and J Jarnet, and M Paris, and E Housset, and M Leclerc
December 2017, Journal of the American Heart Association,
Copied contents to your clipboard!